// App-Quantinova.ai

SAT0336 (2018) : Measurement properties of the minimal disease activity criteria for psoriatic arthritis

Researchers

Presenter

  • L.C. Coates

Principal Investigators

  • V. Strand

  • H. Wilson

  • B.S. Stolshek

  • A. Samad

  • J. Chung

  • D.D. Gladman

  • P. Mease

Medical Centers

  • OCDEM, University of Oxford, Oxford, UK

  • Division of Hematology, Stanford University, Stanford, CA

  • Evidera, Seattle, WA

  • Amgen Inc, Thousand Oaks, CA

  • University of Toronto and Toronto Western Hospital, Toronto, Canada

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

Locations

  • United Kingdom

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • Malondialdehyde

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • Abbvie

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved